image
Aclarion, Inc. ACONW
Healthcare - Medical - Healthcare Information Services - NASDAQ - US
Watchlist
$ 0.036
2.86 %
$ 1.76 M
Market Cap
-0.01
P/E
1. INTRINSIC VALUE

Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy (MRS) in the United States. It offers NOCISCAN-LS Post-Processor suite comprising NOCICALC-LS that receives and processes the acquired disc MRS data to calculate levels of degenerative pain biomarkers; and NOCIGRAM-LS, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was founded in 2008 and is based in San Mateo, California.[ Read More ]

The intrinsic value of one ACONW stock under the base case scenario is HIDDEN Compared to the current market price of 0.036 USD, Aclarion, Inc. is HIDDEN

ACONW Intrinsic Value
HIDDEN
SHOW
2. FUNDAMENTAL ANALYSIS

Price Chart ACONW

image
FINANCIALS
75.4 K REVENUE
24.75%
Growth Rates
1Year 24.75%
3Years 15.73%
5Years 0.00%
7Years 0.00%
10Years 0.00%
-4.88 M OPERATING INCOME
20.05%
Growth Rates
1Year 20.05%
3Years -2.88%
5Years 0.00%
7Years 0.00%
10Years 0.00%
-4.91 M NET INCOME
35.42%
Growth Rates
1Year 35.42%
3Years -1.95%
5Years 0.00%
7Years 0.00%
10Years 0.00%
-3.65 M OPERATING CASH FLOW
31.37%
Growth Rates
1Year 31.37%
3Years 1.32%
5Years 0.00%
7Years 0.00%
10Years 0.00%
-120 K INVESTING CASH FLOW
42.50%
Growth Rates
1Year 42.50%
3Years 12.60%
5Years 0.00%
7Years 0.00%
10Years 0.00%
3.31 M FINANCING CASH FLOW
-49.41%
Growth Rates
1Year -49.41%
3Years -4.96%
5Years 0.00%
7Years 0.00%
10Years 0.00%
14.4 K REVENUE
31.32%
Growth Rates
1Year 24.75%
3Years 15.73%
5Years 0.00%
7Years 0.00%
10Years 0.00%
-1.3 M OPERATING INCOME
-14.12%
Growth Rates
1Year 20.05%
3Years -2.88%
5Years 0.00%
7Years 0.00%
10Years 0.00%
-1.37 M NET INCOME
-10.35%
Growth Rates
1Year 35.42%
3Years -1.95%
5Years 0.00%
7Years 0.00%
10Years 0.00%
-800 K OPERATING CASH FLOW
31.50%
Growth Rates
1Year 31.37%
3Years 1.32%
5Years 0.00%
7Years 0.00%
10Years 0.00%
-104 K INVESTING CASH FLOW
-10.47%
Growth Rates
1Year 42.50%
3Years 12.60%
5Years 0.00%
7Years 0.00%
10Years 0.00%
1.04 M FINANCING CASH FLOW
453.26%
Growth Rates
1Year -49.41%
3Years -4.96%
5Years 0.00%
7Years 0.00%
10Years 0.00%
Balance Sheet Decomposition Aclarion, Inc.
image
Current Assets 1.29 M
Cash & Short-Term Investments 1.02 M
Receivables 13.4 K
Other Current Assets 255 K
Non-Current Assets 1.17 M
Long-Term Investments 0
PP&E 1.78 K
Other Non-Current Assets 1.17 M
Current Liabilities 3.19 M
Accounts Payable 761 K
Short-Term Debt 1.13 M
Other Current Liabilities 1.3 M
Non-Current Liabilities 0
Long-Term Debt 0
Other Non-Current Liabilities 0
EFFICIENCY
Earnings Waterfall Aclarion, Inc.
image
Revenue 75.4 K
Cost Of Revenue 75.7 K
Gross Profit -324
Operating Expenses 4.88 M
Operating Income -4.88 M
Other Expenses 35.4 K
Net Income -4.91 M
RATIOS
-0.43% GROSS MARGIN
-0.43%
Averages
1Year -0.43%
3Years -7.73%
5Years -38.85%
7Years 0.00%
10Years 0.00%
-6466.48% OPERATING MARGIN
-6466.48%
Averages
1Year -6466.48%
3Years -7151.30%
5Years -9115.59%
7Years 0.00%
10Years 0.00%
-6513.41% NET MARGIN
-6513.41%
Averages
1Year -6513.41%
3Years -9150.20%
5Years -10451.59%
7Years 0.00%
10Years 0.00%
674.64% ROE
674.64%
Averages
1Year 674.64%
3Years 75.55%
5Years 106.15%
7Years 0.00%
10Years 0.00%
-199.67% ROA
-199.67%
Averages
1Year -199.67%
3Years -223.65%
5Years -264.62%
7Years 0.00%
10Years 0.00%
-1225.96% ROIC
-1225.96%
Averages
1Year -1225.96%
3Years -526.03%
5Years -228.22%
7Years 0.00%
10Years 0.00%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis Aclarion, Inc.
image
Net Income -4.91 M
Depreciation & Amortization 163 K
Capital Expenditures -120 K
Stock-Based Compensation 456 K
Change in Working Capital 623 K
Others 427 K
Free Cash Flow -3.77 M
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets Aclarion, Inc.
image
ACONW has no price targets from Wall Street.
4. DIVIDEND ANALYSIS
0.70% DIVIDEND YIELD
0 USD DIVIDEND PER SHARE
5. COMPETITION

Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy (MRS) in the United States. It offers NOCISCAN-LS Post-Processor suite comprising NOCICALC-LS that receives and processes the acquired disc MRS data to calculate levels of degenerative pain biomarkers; and NOCIGRAM-LS, a clinical decision support software.

image
-2.28 USD
ACON
Overvalued 1498.70%

HeartBeam, Inc. is a development stage company, which engages in cardiovascular diagnostic technology. Its electrocardiogram (ECG) collection device provides physicians with cardiac diagnostic information for a patient that is outside of a medical institution.

image
0.796 USD
BEATW
Undervalued 13.76%

Edible Garden AG Incorporated and its subsidiaries operate as a controlled environment agriculture farming company. It offers various products, including individually potted, live herbs, cut single-herb clamshells, specialty herb items, various types of lettuce, hydro basil, bulk basil, and vegan protein powder.

image
-0.0484 USD
EDBLW
Overvalued 349.24%
6. Ownership
Insider Ownership Aclarion, Inc.
image
Sold
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
Date Value Insider Amount Avg Price
1 year ago
Feb 16, 2023
Bought 1 K USD
Thramann Jeffrey John
Executive Chairman
+ 1
 1000 USD
1 year ago
Dec 29, 2022
Bought 4.47 K USD
Ness Brent
Chief Executive Officer
+ 7711
 0.58 USD
1 year ago
Dec 29, 2022
Bought 4.34 K USD
Ness Brent
Chief Executive Officer
+ 8500
 0.51 USD
1 year ago
Dec 28, 2022
Bought 961 USD
Ness Brent
Chief Executive Officer
+ 2289
 0.42 USD
1 year ago
Dec 29, 2022
Bought 8.24 K USD
Lorbiecki John Paul
Chief Financial Officer
+ 18304.441
 0.45 USD
1 year ago
Dec 29, 2022
Bought 1.76 K USD
Lorbiecki John Paul
Chief Financial Officer
+ 4100
 0.43 USD
7. News
8. Profile Summary

Aclarion, Inc. ACONW

image
COUNTRY US
INDUSTRY Medical - Healthcare Information Services
MARKET CAP $ 1.76 M
Dividend Yield 0.70%
Description Aclarion, Inc., a healthcare technology company, develops software application for magnetic resonance spectroscopy (MRS) in the United States. It offers NOCISCAN-LS Post-Processor suite comprising NOCICALC-LS that receives and processes the acquired disc MRS data to calculate levels of degenerative pain biomarkers; and NOCIGRAM-LS, a clinical decision support software. The company was formerly known as Nocimed, Inc. and changed its name to Aclarion, Inc. in December 2021. Aclarion, Inc. was founded in 2008 and is based in San Mateo, California.
Contact 951 Mariners Island Boulevard, San Mateo, CA, 94404 https://www.aclarion.com
IPO Date None
Employees 4
Officers Mr. John Lorbiecki Chief Financial Officer Mr. Brent Ness Chief Executive Officer, President & Director Mr. Ryan Bond Chief Strategy Officer Dr. Jeffrey John Thramann M.D. Executive Chairman